PreClinical CRO dedicated to your NonClinical projects
Pulmonary Arterial Hypertension (PAH) is an orphan disease, incurable that remains highly lethal despite recent advanced medical treatment.
Syncrosome invites you to visit us at Neuroconnection in Marseille the 1st and 2nd July. In the framework of the European project NeuroRescue, this symposium is an European event around technological innovation and private-public partnerships in NEUROSCIENCES and AGEING.
Diabetes is a chronic metabolic disorder, caused by a failure of the body to produce insulin and/or an inability of the body to respond adequately to circulating insulin. The WHO estimates that 346 million people worldwide have diabetes.
Is your company involved in the development of Cardiovascular, Respiratory, Gastroinestinal or Central Nervous System drugs? Are you considering to test new or existing products for the prevention and treatment of various disease?
DRUG EVALUATION SERVICES:
How can I find the information I am looking for?
To have a overview of our services go to the homepage.
More detailled information in the sub pages of "drug evaluation services":
- Drug efficacy
- In Vivo pharmacokinetics
- Safety assessment
We can provide you with a combinated form of these studies for example
- Efficacy and early safety in the same experiment.
- Efficacy and Pharmacokinetics: advanced PK/PD.
- Safety and Pharmacokinetics: DMPK.
The main objective of combined studies is to improve scientific relevance by analysing the safety and pharmacokinetics aspects of your compounds on the same species which has been used for efficacy.
Combined studies allow for a reduction in the number of animal subjects used.
The final benefit of combined studies is to optimize the use of your budget!